Učitavanje...
20 µg versus >20 µg estrogen combined oral contraceptives for contraception
BACKGROUND: Concern about estrogen‐related adverse effects has led to progressive reductions in the estrogen dose in combination oral contraceptives (COCs). However, reducing the amount of estrogen to improve safety could result in decreased contraceptive effectiveness and unacceptable changes in bl...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2013
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173696/ https://ncbi.nlm.nih.gov/pubmed/23904209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003989.pub5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|